Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.43 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.43 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.43 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362539 | 1.00 | GABRA1 (0.50) | GABRA1GABRB2HSPA5ANPEPDPP4 | |
| SCHEMBL323999 | 0.98 | GABRA1 (0.48) | GABRA1GABRB2HSPA5ANPEPDPP4 | |
| Ammonia Solution, Strong SCHEMBL324961 | 0.98 | GABRA1 (0.48) | GABRA1GABRB2HSPA5ANPEPDPP4 | |
| SCHEMBL198461 | 0.85 | CSNK2A2 (0.52) | GABRA1GABRB2DPP4ALDH1A1CSNK2A2 | |
| SCHEMBL5587931 | 0.85 | GABRA1 (0.56) | GABRA1GABRB2HSPA5ANPEPDPP4 | |
| SCHEMBL10679098 | 0.84 | GABRA1 (0.48) | GABRA1GABRB2HSPA5ANPEPDPP4 | |
| SCHEMBL9638702 | 0.84 | ANPEP (0.49) | GABRA1GABRB2HSPA5ANPEPDPP4 | |
| SCHEMBL983104 | 0.84 | GABRA1 (0.48) | GABRA1GABRB2HSPA5ANPEPDPP4 | |
| SCHEMBL10011887 | 0.84 | HSP90AA1 (0.50) | GABRA1GABRB2ANPEPDPP4ALDH1A1 | |
| SCHEMBL11382359 | 0.83 | CSNK2A2 (0.50) | GABRA1GABRB2DPP4ALDH1A1CSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113122241-A | Quantum dot material and preparation method thereof, quantum dot light-emitting diode and light-emitting device | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| EP-0596129-A1 | PHASE DIFFERENCE COMPENSATION FILM | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1994-05-11 | — | — | EP | claimed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| EP-4202013-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | Fushimi Pharmaceutical Co., Ltd. (JP) | 2023-06-28 | — | — | EP | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| EP-2275405-B1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | ASAHI CHEMICAL IND (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-2275406-B1 | PROCESS FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2018-11-28 | — | — | EP | disclosed |
| CN-105246940-B | Optical semiconductor sealing solidification compound | 株式会社大赛璐 | 2018-09-04 | — | — | CN | disclosed |
| CN-108430970-A | Bisphenol compound and aromatic copolycarbonate | 本州化学工业株式会社 | 2018-08-21 | — | — | CN | disclosed |
| EP-2792673-B1 | Carbamic acid ester derivatives for the production of isocyanate and aromatic hydroxy compounds | ASAHI CHEMICAL IND (JP) | 2018-07-25 | — | — | EP | disclosed |
| CN-101186577-A | Liquid crystal monomer with reaction character and preparation method thereof | NORTHWEST IND UNIVERSITY (CN) | 2008-05-28 | — | — | CN | disclosed |
| CN-101007798-A | Benzodioxole derivatives and their preparation method and medicinal uses | POISON MED INST PLA MED ACAD (CN) | 2007-08-01 | — | — | CN | disclosed |
| US-6391925-B1 | MICROBIOCIDES; ANTISEPTICS | ECOLAB INC. | 2002-05-21 | — | — | US | disclosed |
| EP-0778821-B1 | ORTHO-SUBSTITUTED AROMATIC ETHER COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR PAIN RELIEF | ZENECA LTD (GB) | 1999-10-20 | — | — | EP | disclosed |
| US-5965741-A | ANTIINFLAMMATORY, ANTIPYRETIC AND ANTIDIARRHOEAL PROPERTIES | ZENECA LIMITED (GB) | 1999-10-12 | — | — | US | disclosed |
| EP-0786699-A1 | Positive photoresist composition | Fuji Photo Film Co., Ltd. (JP) | 1997-07-30 | — | — | EP | disclosed |
| EP-0778821-A1 | ORTHO-SUBSTITUTED AROMATIC ETHER COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR PAIN RELIEF | ZENECA LIMITED (GB) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996006822-A1 | ORTHO-SUBSTITUTED AROMATIC ETHER COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR PAIN RELIEF | ZENECA LIMITED (GB) | 1996-03-07 | — | — | WO | disclosed |
| EP-0596129-A1 | PHASE DIFFERENCE COMPENSATION FILM | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1994-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | PFAS, PHOSPHO1, PAF1 | GABRA1 2733/4885GABRB2 2758/4885HSPA5 4078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.